Today's Portrait Highlights

Joint Polish Investment Fund

JPIF aims to create high returns by focusing on investments in Life Science companies with visible value inflection points. The fund is based in the Netherlands with an experienced, international team operating out of Warsaw, Poland. JPIF will invest in early and mid stage Life Science companies in Central and Eastern Europe with an investment holding period of 3-5 years. In addition the JPIF team will also look at Polish companies which have licensed, partnered or acquired technologies from abroad. JPIF's aim is to create a high return investment portfolio that leverages the Polish life science cababilities

mfore

mfore provides the technology platform and service for healthcare providers, to utilize mobile communication channels to have a continuous dialogue with patients and care givers (e.g. family members) outside the care setting and between encounters. Our offering enables healthcare providers to converse with patients and care givers with relevant information at right times to educate, remind and reinforce the prescribed care and get insights to patient’s progress in the care process.

Asper Biotech

Asper Biotech is a genetic testing company founded in 1999. Various testing menus encompass tests addressed to the diagnostics of a number of diseases - ophthalmological, neurological, cardiological, oncological ones among others. The quality of the testing procedures is confirmed by CLIA, ISO 15189:2008 and ISO 9001:2008 certifications. Asper Biotech serves clients, including leading university hospitals, private clinics, commercial laboratories and research organisations from more than 40 countries.